Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma

doi:10.3748/wjg.v21.i13.3960

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7936)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

531

WORD

309

HTML

4017

Figures (1-4)

226

Tables (1-4)

236

Sum=5319

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

966

Download

1651

Sum=2617

Apr 7, 2015 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 7, 2015; 21(13): 3960-3969
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3960

Full Size Figure Download Figure

Figure 4 Correlation analyses between gene methylation and the survival of hepatocellular carcinoma patients. A: Survival was analyzed using Kaplan-Meier curves. The plots were made according to the patients with IRAK3 and GLOXD1 methylation and 3-year overall survival in 98 hepatocellular carcinoma (HCC) patients, respectively; B: Kaplan-Meier survival curves were made according to the cases with GLOXD1 and IRAK3 methylation and 3-year disease-free survival in 57 HCC patients (P = 0.0386, log-rank test, UM, unmethylated cases vs M, methylated cases).

Citation: Kuo CC, Shih YL, Su HY, Yan MD, Hsieh CB, Liu CY, Huang WT, Yu MH, Lin YW. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3960-3969
URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3960.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i13.3960